Items where authors include "Hayward, NK"

Article

Mangantig, E, MacGregor, S, Iles, MM orcid.org/0000-0002-2603-6509 et al. (17 more authors) (2020) Germline variants are associated with increased primary melanoma tumor thickness at diagnosis. Human Molecular Genetics, 29 (21). pp. 3578-3587. ISSN 0964-6906

Law, MH, Aoude, LG, Duffy, DL et al. (19 more authors) (2020) Multiplex melanoma families are enriched for polygenic risk. Human Molecular Genetics. ISSN 0964-6906

Landi, MT, Bishop, DT orcid.org/0000-0002-8752-8785, MacGregor, S et al. (158 more authors) (2020) Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature Genetics, 52 (5). pp. 494-504. ISSN 1061-4036

Duffy, DL, Zhu, G, Li, X et al. (42 more authors) (2019) Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nature Communications, 10. 299. ISSN 2041-1723

Duffy, DL, Zhu, G, Li, X et al. (42 more authors) (2018) Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nature Communications, 9. 4774. ISSN 2041-1723

Taylor, NJ, Mitra, N, Goldstein, AM et al. (41 more authors) (2017) Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. Journal of Investigative Dermatology, 137 (12). pp. 2606-2612. ISSN 0022-202X

Choi, J, Xu, M, Makowski, MM et al. (16 more authors) (2017) A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF. Nature Genetics, 49 (9). pp. 1287-1413. ISSN 1061-4036

Harland, M, Petljak, M, Robles-Espinoza, CD et al. (13 more authors) (2016) Germline TERT promoter mutations are rare in familial melanoma. Familial Cancer, 15 (1). pp. 139-144. ISSN 1389-9600

Law, M, Bishop, DT orcid.org/0000-0002-8752-8785, Lee, JE et al. (78 more authors) (2015) Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nature Genetics, 47 (9). pp. 987-995. ISSN 1061-4036

Freitag, DF, Butterworth, AS, Willeit, P et al. (150 more authors) (2015) Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. Lancet Diabetes and Endocrinology, 3 (4). pp. 243-253. ISSN 2213-8587

Levine, DM, Ek, WE, Zhang, R et al. (31 more authors) (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nature Genetics, 45 (12). pp. 1487-1493. ISSN 1061-4036

Preprint

Ranzani, M, Kemper, K, Michaut, M et al. (35 more authors) (2017) A screen for combination therapies in<i>BRAF/NRAS</i>wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination. [Preprint]